Description
Repaglinide Tablets IP
Composition:
Each uncoated tablet contains:
Repaglinide IP 0.5 mg
INDICATION & USE
• Diabetes Mellitus
• Diabetes with Obesity
• Diabetes Mellitus
• Diabetes with Obesity
Each uncoated tablet contains:
Repaglinide IP 0.5 mg
• Diabetes Mellitus
• Diabetes with Obesity
Shince Pharmaceuticals Pvt Ltd., a division of Surien Pharmaceuticals (P) Ltd., delivers excellence in pharmaceutical manufacturing and innovation worldwide.
Reviews
There are no reviews yet.